Bionomics Ltd (BNO.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 166 | 166 | 165 | 166 | 166 |
| Accounts receivable | 10 | 13 | 11 | 80 | 11 |
| Accounts payable and accrued liabilities | 216 | 581 | -785 | 205 | -918 |
| Other Working Capital | 1,397 | 1,806 | -643 | -328 | -1,199 |
| Other Operating Activity | -5,584 | -6,150 | 12,705 | -3,481 | -2,493 |
| Operating Cash Flow | $-3,795 | $-3,585 | $11,453 | $-3,358 | $-4,433 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,254 | 705 | 824 | 0 | 0 |
| Other Financing Activity | 0 | 0 | 339 | -112 | -227 |
| Financing Cash Flow | $3,254 | $705 | $1,163 | $-112 | $-227 |
| Exchange Rate Effect | -19 | 50 | 85 | -277 | 138 |
| Beginning Cash Position | 14,289 | 17,119 | 4,419 | 8,165 | 12,687 |
| End Cash Position | 13,728 | 14,289 | 17,119 | 4,419 | 8,165 |
| Net Cash Flow | $-541 | $-2,880 | $12,616 | $-3,470 | $-4,660 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,795 | -3,585 | 11,453 | -3,358 | -4,433 |
| Free Cash Flow | -3,795 | -3,585 | 11,453 | -3,358 | -4,433 |